Pages that link to "Q41140718"

The following pages link to Inhaled micronised gentamicin powder: a new delivery system (Q41140718):

Displaying 16 items.

• The role of disposable inhalers in pulmonary drug delivery. (Q30368417) (← links)
• Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle (Q34135440) (← links)
• Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy (Q35012435) (← links)
• An alternative aerosol delivery system for amiloride (Q36685874) (← links)
• Delivery of antibiotics to the respiratory tract: an update (Q37564542) (← links)
• Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology (Q37851986) (← links)
• Pharmaceutical aerosols for the treatment and prevention of tuberculosis (Q38042953) (← links)
• Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis (Q38630919) (← links)
• Aerosol antibiotic treatment in cystic fibrosis (Q40826267) (← links)
• Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study (Q41071899) (← links)
• Microparticles for inhalational delivery of antipseudomonal antibiotics (Q41843336) (← links)
• Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. (Q44041707) (← links)
• Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients. (Q51056286) (← links)
• [Inhalation antibiotherapy] (Q73159290) (← links)
• Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study Group (Q77461075) (← links)
• [Administration of anti-infective agents through the inhaled route] (Q80523150) (← links)